|
Index of reports
> Cases resulting in other serious reactions (57)
> Cases with Blood Creatine Phosphokinase Increased (7)
Below is the selection of adverse event reports related to Amaryl (Glimepiride) that includes cases resulting in other serious reactions where reactions include blood creatine phosphokinase increased.
Adverse event in 74 year old male receiving Amaryl (Glimepiride)
Reported by a pharmacist from Japan on 2007-10-23
Patient: 74 year old male
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased
Suspect drug(s):
Amaryl (Glimepiride)
Other drugs received by patient: Lipitor
Adverse event in 74 year old male receiving Amaryl (Glimepiride)
Reported by a pharmacist from Japan on 2007-10-11
Patient: 74 year old male
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased
Suspect drug(s):
Amaryl (Glimepiride)
Other drugs received by patient: Lipitor
Adverse event in 69 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-07-03
Patient: 69 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Weight Decreased, White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Monocyte Count Increased, Hypokalaemia, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Blood Sodium Increased, Oedema, Platelet Count Decreased, Muscle Spasms
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
Indication: Oedema
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Start date: 2007-04-04
Other drugs received by patient: Aldactone
Adverse event in 61 year old male receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-06-25
Patient: 61 year old male
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased
Suspect drug(s):
Amaryl (Glimepiride)
Other drugs received by patient: Glimicron; Glimicron
Adverse event in 69 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-06-06
Patient: 69 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Weight Decreased, White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Monocyte Count Increased, Hypokalaemia, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Blood Sodium Increased, Oedema, Platelet Count Decreased, Muscle Spasms
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
Indication: Oedema
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Start date: 2007-04-04
Other drugs received by patient: Aldactone
Adverse event in 69 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-05-23
Patient: 69 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Weight Decreased, White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Monocyte Count Increased, Muscle Twitching, Hypokalaemia, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Oedema, Blood Sodium Increased, Platelet Count Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
Indication: Oedema
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Start date: 2007-04-04
Other drugs received by patient: Aldactone
Adverse event in 69 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-04-30
Patient: 69 year old female
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
|
